Navigation Links
Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
Date:5/22/2012

SAN FRANCISCO, May 22, 2012 /PRNewswire/ -- Boehringer Ingelheim announced today results from a Phase II study evaluating the investigational compound tiotropium delivered once-daily via the Respimat® Inhaler in adolescents with symptomatic, moderate persistent asthma. The data were presented at the 2012 Annual Meeting of the American Thoracic Society (ATS 2012). Boehringer Ingelheim announced that a comprehensive confirmatory Phase III trial program named UniTinA-asthma™ is ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma in pediatric, adolescent and adult patients. 

The results are from a Phase II, 4-week, randomized, double-blind, placebo-controlled, incomplete cross-over study. This dose-ranging study evaluated 105 patients 12 to 17 years of age with moderate, persistent asthma on medium dose inhaled corticosteroids (ICS) with or without long-acting beta-agonist (LABA) or leukotriene receptor antagonists (LTRA). 

With all dosages of tiotropium administered once daily, lung function was greater as evaluated by peak FEV1(0-3h) (1.25 microgram = 0.566 L; 2.5 microgram = 0.546 L; 5 microgram = 0.602 L), 1.25FEV1AUC(0-3h)  (1.25 microgram = 0.455 L; 2.5 microgram = 0.434 L; 5 microgram = 0.497 L) and trough FEV1 (1.25 microgram = 0.384 L; 2.5 microgram = 0.353 L; 5 microgram = 0.442 L) compared to placebo (0.489 L, 0.363 L, 0.292 L, respectively). A statistically significant increase in lung function was observed with 5 microgram tiotropium administered once daily (peak FEV1(0-3h)  = 0.113 L, p = 0.004; FEV1AUC(0-3h) = 0.133 L, p<0.001;  trough FEV1 = 0.151 L, p<0.001). The 5 microgram dose was chosen for further studies of tiotropium in this patient population.

"Despite substantial advancements in the treatment of asthma and a wide range of available therapeutic optio
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
2. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
3. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
4. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
5. Phase 2b Study of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Shows Undetectable Virus in HCV Genotype-1 Patients 12 Weeks After Treatment Ended (SVR12)
6. Boehringer Ingelheim and Lillys new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies
7. Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the Development, Manufacture, and Supply of Biosuperior Monoclonal Antibodies
8. CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
9. AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim
10. Boehringer Ingelheim Invests More Than $350 Million in 2011 U.S. Expansion Projects
11. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... CUPERTINO, Calif., Aug. 3, 2015  DURECT Corporation (Nasdaq: ... of 2015.  Total revenues were $4.4 million and net loss ... 2015 as compared to total revenues of $4.6 million and ... June 30, 2014.At June 30, 2015, we had cash and ... $34.9 million at December 31, 2014.  At June 30, 2015, ...
(Date:8/3/2015)... ReportsnReports.com adds Global Medical ... forecasts as well as Global Medical Simulation Market ... collection of its library. Complete 2015 ... spread across 164 pages, talking about 7 major ... is now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html . ...
(Date:8/3/2015)... , Aug. 3, 2015 Ortho Clinical Diagnostics ... been named Chief Corporate Brand and Communications Officer, effective ... leadership team, Bouryal will lead the company,s worldwide corporate ... its transition to an independent company by adding sites ... Chairman and Chief Executive Officer Dr. Martin Madaus ...
Breaking Medicine Technology:DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2
... , SAN DIEGO, Nov. 5 ResMed Inc. (NYSE: ... the quarter ended September 30, 2009. Revenue for the September ... increase on a constant currency basis) over the quarter ended ... income from operations was $52.7 million and net income was ...
... InterMune, Inc. (Nasdaq: ITMN ) today announced results from ... 2009. InterMune reported a net loss for the ... compared with a net loss of $14.0 million, or $0.36 per ... Chief Executive Officer and President of InterMune, said, "The third quarter ...
Cached Medicine Technology:ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009 2ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009 3ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009 4ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009 5ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009 6ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 2InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 3InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 4InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 8InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 9InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 10InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 11InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 12InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 13
(Date:8/4/2015)... ... August 04, 2015 , ... The goal of looking younger – ... for invasive surgery to achieve this ideal is not. But minimally invasive procedures such ... the high cost or lengthy recovery time, according to Valerie Goldburt, MD, PhD ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... national talcum powder lawsuits filed against Johnson & Johnson report that a new ... powder lawyers provide regular news updates and cancer warning information at their ...
(Date:8/4/2015)... ... 04, 2015 , ... Please join us for the 4th Annual Doris ... Oneida Shores Park in Brewerton, NY. , Doris Connor was a healthy, active, ... young age of 59. Her family and friends have since become steadfast in their ...
(Date:8/4/2015)... ... August 04, 2015 , ... Mr Didier Cauchois, CIO of ... far". , Mr Cauchois attributes the success to the dedication from the ... the healthcare technology offered by Winscribe's platform. , "We have already begun ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... partnership to make the Isabel Symptom Checker available to all users of the ... mechanism to check their symptoms in an easy, intuitive method, provides access to ...
Breaking Medicine News(10 mins):Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 2Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3
... on XM Satellite Radio,and The United States Army ... new 13 week programming series designed to highlight ... internal,medicine, medical education and much more., This ... medical,professionals and those interested in a career in ...
... are a tremendous,hardship for everyone they affect, but ... can be even more catastrophic., Listen to ... Association of,Clinical Endocrinologists at:, http://media.medialink.com/WebNR.aspx?story=35281 , Registered ... for free and unrestricted use at http://www.mediaseed.tv ...
... Colonial Life & Accident,Insurance Company has set up dedicated phone lines ... Midwest to get support from the,company., (Logo: http://www.newscom.com/cgi-bin/prnh/20080109/CLW033LOGO ... free at these,numbers:, Policyholders: ... ...
... Increase Would Generate More Than $150 Million in New ... leaders,begin working next week to resolve a projected state ... $1 cigarette tax increase would,raise more than $150 million ... youth smoking, cause many smokers to quit, reduce,tobacco-related health ...
... in 8,000 deaths, 56,000 hospitalizations for those 65 and ... (HealthDay News) -- In 2005, traumatic brain injuries (TBIs) ... 56,000 hospitalizations among Americans age 65 and older, according ... study. , TBIs accounted for 50 percent ...
... determine the anti-inflammatory value of diets rich in some ... have found that a molecule produced by the body ... distress in laboratory mice. The research, supported by the ... the National Institutes of Health, was led by a ...
Cached Medicine News:Health News:The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called 'The Strength to Heal' That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio. 2Health News:The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called 'The Strength to Heal' That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio. 3Health News:Support Numbers for Colonial Life & Accident Insurance Company Customers Affected by Floods 2Health News:New Report: Increasing Mississippi's Cigarette Tax Will Reduce Smoking, Save Lives and Save Money 2Health News: Senior Falls Can Lead to Brain Injury 2
Practice-oriented ophthalmic laser systems for photodisruption....
... for determining color vision abnormalities and testing ... be applied to many psychological and industrial ... four trays containing a total of 85 ... hue variation on one side and are ...
... the Farnsworth-Munsell 100 Hue Test. It is intended ... study of a color vision defect. It provides ... difficulty in distinguishing color differences in certain tasks. ... reference caps with Munsell notations, plus a neutral ...
Magnetic Farnsworth D15 kit. Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
Medicine Products: